IL2 and neoplasm: In a follow-up study the same authors showed that the IL-2/CD25 fusion protein also induces anti-tumor immune response in the absence of a vaccine and outperforms an IL-2Rβγc biased IL-2v (IL-2/anti-IL-2 S4B6 complexes).